4.6 Article

SARM Is Required for Neuronal Injury and Cytokine Production in Response to Central Nervous System Viral Infection

Journal

JOURNAL OF IMMUNOLOGY
Volume 191, Issue 2, Pages 875-883

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1300374

Keywords

-

Categories

Funding

  1. National Institutes of Health [NS060885]
  2. National Institute of Allergy and Infectious Diseases [U19AI083025]

Ask authors/readers for more resources

Four of the five members of the Toll/IL-1R domain-containing adaptor family are required for signaling downstream of TLRs, promoting innate immune responses against different pathogens. However, the role of the fifth member of this family, sterile a and Toll/IL-1R domain-containing 1 (SARM), is unclear. SARM is expressed primarily in the CNS where it is required for axonal death. Studies in Caenorhabditis elegans have also shown a role for SARM in innate immunity. To clarify the role of mammalian SARM in innate immunity, we infected SARM(-/-) mice with a number of bacterial and viral pathogens. SARM(-/-) mice show normal responses to Listeria monocytogenes, Mycobacterium tuberculosis, and influenza virus, but show dramatic protection from death after CNS infection with vesicular stomatitis virus. Protection correlates with reduced CNS injury and cytokine production by nonhematopoietic cells, suggesting that SARM is a positive regulator of cytokine production. Neurons and microglia are the predominant source of cytokines in vivo, supporting a role for SARM as a link between neuronal injury and innate immunity. The Journal of Immunology, 2013, 191: 875-883.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Virology

SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice

Emma S. Winkler, Rita E. Chen, Fahmida Alam, Soner Yildiz, James Brett Case, Melissa B. Uccellini, Michael J. Holtzman, Adolfo Garcia-Sastre, Michael Schotsaert, Michael S. Diamond

Summary: The study developed a mouse model for SARS-CoV-2 infection by introducing the human ACE2 gene into the mouse genome, providing insights into viral replication and pathology in mice. Additionally, the study identified the impact of the N501Y mutation in mice on viral replication and pathogenesis.

JOURNAL OF VIROLOGY (2022)

Article Virology

Human SUMOylation Pathway Is Critical for Influenza B Virus

Runrui Dang, Victor G. J. Rodgers, Adolfo Garcia-Sastre, Jiayu Liao

Summary: This study identifies the human SUMOylation pathway as a critical host factor for the IBV viral life cycle. Inhibiting this pathway effectively blocks the replication of IBV, providing a novel strategy for the development of anti-viral therapeutics.

VIRUSES-BASEL (2022)

Article Virology

Obesity and Metabolic Dysregulation in Children Provide Protective Influenza Vaccine Responses

Mundeep K. Kainth, Joanna S. Fishbein, Teresa Aydillo, Alba Escalera, Rachael Odusanya, Kalliopi Grammatikopoulos, Tiffany Scotto, Christine B. Sethna, Adolfo Garcia-Sastre, Clifford S. Deutschman

Summary: This study investigated antibody and cytokine responses following influenza vaccination in obese children. The results showed that obesity did not alter the efficacy of the vaccine, regardless of metabolic health. However, metabolically unhealthy obese children had decreased IL-13 levels, which may be associated with altered inflammatory response.

VIRUSES-BASEL (2022)

Review Microbiology

Advances and gaps in SARS-CoV-2 infection models

Cesar Munoz-Fontela, Lina Widerspick, Randy A. Albrecht, Martin Beer, Miles W. Carroll, Emmie de Wit, Michael S. Diamond, William E. Dowling, Simon G. P. Funnell, Adolfo Garcia-Sastre, Nora M. Gerhards, Rineke de Jong, Vincent J. Munster, Johan Neyts, Stanley Perlman, Douglas S. Reed, Juergen A. Richt, Ximena Riveros-Balta, Chad J. Roy, Francisco J. Salguero, Michael Schotsaert, Lauren M. Schwartz, Robert A. Seder, Joaquim Segales, Seshadri S. Vasan, Ana Maria Henao-Restrepo, Dan H. Barouch

Summary: Animal models play a crucial role in evaluating the virulence, transmission, and immune escape of SARS-CoV-2 variants and are continuously being improved to better replicate the demographic characteristics of COVID-19.

PLOS PATHOGENS (2022)

Article Biochemistry & Molecular Biology

Structure-Activity Relationships and Transcriptomic Analysis of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors

Andrey A. Poloznikov, Sergey V. Nikulin, Dmitry M. Hushpulian, Anna Yu. Khristichenko, Andrey I. Osipyants, Andrey F. Asachenko, Olga V. Shurupova, Svyatoslav S. Savin, Sue H. Lee, Irina N. Gaisina, Gregory R. J. Thatcher, Anthony Narciso, Eric P. Chang, Sergey V. Kazakov, Nancy Krucher, Vladimir I. Tishkov, Bobby Thomas, Irina G. Gazaryan

Summary: This study evaluated the differences in action of commercially available 2-oxoglutarate mimetics and branched-tail oxyquinoline inhibitors of hypoxia-inducible factor prolyl hydroxylase (HIF PHD). Novel oxyquinoline inhibitors were identified to be more active than existing ones and showed opposite effects on certain signaling pathways.

ANTIOXIDANTS (2022)

Review Virology

Type I and Type II Interferon Antagonism Strategies Used by Paramyxoviridae: Previous and New Discoveries, in Comparison

Giuseppe Pisanelli, Ugo Pagnini, Giuseppe Iovane, Adolfo Garcia-Sastre

Summary: Paramyxoviruses are negative single-strand RNA viruses that can cause significant diseases in humans and animals. These viruses have evolved different strategies to evade the host's interferon defense mechanism, which is activated upon viral recognition and leads to the production of interferons that reduce viral replication. This article analyzes the current status of the various strategies used by paramyxoviruses to bypass interferon responses.

VIRUSES-BASEL (2022)

Article Microbiology

Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine

Aitor Nogales, John Steel, Wen-Chun Liu, Anice C. Lowen, Laura Rodriguez, Kevin Chiem, Andrew Cox, Adolfo Garcia-Sastre, Randy A. Albrecht, Stephen Dewhurst, Luis Martinez-Sobrido

Summary: The study demonstrates that introducing the L319Q substitution in the PB1 protein of the pH1N1 influenza virus can lead to the generation of a less pathogenic and transmissible attenuated virus, providing a basis for the development of a novel LAIV based on a contemporary pH1N1 strain.

MICROBIOLOGY SPECTRUM (2022)

Article Biochemistry & Molecular Biology

BACH1-Hemoxygenase-1 axis regulates cellular energetics and survival following sepsis

Lun Cai, Ali S. Arbab, Tae Jin Lee, Ashok Sharma, Bobby Thomas, Kazuhiko Igarashi, Raghavan Pillai Raju

Summary: The deletion of Bach1 gene improves organ function and survival in sepsis. It enhances antioxidant response, reduces oxidative stress and inflammation, preserves mitochondrial function, and regulates gene expression related to lipid metabolism. Bach1 deficiency also improves liver and lung blood flow in septic mice.

FREE RADICAL BIOLOGY AND MEDICINE (2022)

Article Microbiology

Proteomic Identification of Potential Target Proteins of Cathepsin W for Its Development as a Drug Target for Influenza

Sira C. Gunther, Carles Martinez-Romero, Milagros Sempere Borau, Christine T. N. Pham, Adolfo Garcia-Sastre, Silke Stertz

Summary: This study reveals the importance of cysteine protease cathepsin W (CTSW) in influenza virus replication and identifies the cleavage motif of CTSW substrates. It further discovers the potential proviral role of CTSW in an in vivo model of IAV infection. These findings provide support for the development of drugs targeting CTSW.

MICROBIOLOGY SPECTRUM (2022)

Review Biochemistry & Molecular Biology

Harnessing the Therapeutic Potential of the Nrf2/Bach1 Signaling Pathway in Parkinson's Disease

Manuj Ahuja, Navneet Ammal Kaidery, Debashis Dutta, Otis C. Attucks, Eliot H. Kazakov, Irina Gazaryan, Mitsuyo Matsumoto, Kazuhiko Igarashi, Sudarshana M. Sharma, Bobby Thomas

Summary: Parkinson's disease is a common neurodegenerative disorder characterized by the loss of dopaminergic neurons. Although the exact cause is unclear, oxidative stress, mitochondrial dysfunction, neuroinflammation, and disruption of calcium homeostasis have been proposed as contributing factors. While drugs targeting these pathways have shown promise in preclinical models, a more effective therapeutic approach involving the activation of the Nrf2/Bach1 signaling pathway is being explored. This review discusses the potential benefits of simultaneously inhibiting Bach1 and stabilizing Nrf2 for the treatment of Parkinson's disease.

ANTIOXIDANTS (2022)

Article Chemistry, Medicinal

SARS-CoV-2 Inhibitors Identified by Phenotypic Analysis of a Collection of Viral RNA-Binding Molecules

Alvaro Simba-Lahuasi, Angel Cantero-Camacho, Romel Rosales, Briana Lynn McGovern, M. Luis Rodriguez, Vicente Marchan, Kris M. White, Adolfo Garcia-Sastre, Jose Gallego

Summary: Researchers have identified and characterized RNA-binding compounds that can inhibit the replication of SARS-CoV-2. These compounds were discovered by screening a small library of antiviral compounds and showed promising activity against SARS-CoV-2. Further investigation revealed that these compounds recognize conserved RNA elements in the SARS-CoV-2 genome. These findings provide new possibilities for developing RNA-targeted antivirals and therapeutic agents against coronaviruses.

PHARMACEUTICALS (2022)

Article Immunology

Generation of a high yield vaccine backbone for influenza B virus in embryonated chicken eggs

Sadaf Aslam, Madhusudan Rajendran, Divya Kriti, Andrew Kurland, Jeffrey Johnson, Harm van Bakel, Florian Krammer, Adolfo Garcia-Sastre, Juan Ayllon

Summary: To improve the production yield of seasonal influenza vaccines, we have identified optimal vaccine seed virus backbones for influenza B virus through research and evaluation in embryonated eggs. This study includes 71 strains of influenza B virus from 1940 to the present, representing the known temporal and genetic variability. By assessing the growth profiles and effectiveness of these strains, we selected three strains with the best performance as vaccine seed virus backbones to increase the production yield of influenza B virus seasonal vaccines.

NPJ VACCINES (2023)

Article Biochemistry & Molecular Biology

Emerging small molecule inhibitors of Bach1 as therapeutic agents: Rationale, recent advances, and future perspectives

Dmitry M. Hushpulian, Navneet Ammal Kaidery, Debashis Dutta, Sudarshana M. Sharma, Irina Gazaryan, Bobby Thomas

Summary: Nrf2 is a key regulator of cellular stress response, while Bach1 acts as a feedback regulator. Excessive accumulation of Bach1 interferes with Nrf2 activation, making it crucial to stabilize Nrf2 and inhibit Bach1 for optimal therapeutic benefits. Developing small molecule inhibitors of Bach1 could be a promising neurotherapeutic strategy.

BIOESSAYS (2023)

Article Immunology

Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice

Sonia Jangra, Jeffrey J. Landers, Gabriel Laghlali, Raveen Rathnasinghe, Prajakta Warang, Seok-Chan Park, Jessica. J. O'Konek, Gagandeep Singh, Katarzyna W. Janczak, Adolfo Garcia-Sastre, Nandini Arya, Dilara Karadag, Jr James R. Baker, Michael Schotsaert, Pamela T. Wong

Summary: Multiple FDA-approved vaccines provide good protection against severe disease caused by SARS-CoV-2. However, immunity can decline quickly, especially in the elderly, and new viral variants are emerging that can evade the immune response induced by infection or vaccination. Intranasal vaccination is more effective in inducing mucosal immune responses than injectable vaccines, which can improve protection and reduce viral transmission.

NPJ VACCINES (2023)

Review Immunology

Engineering Non-Human RNA Viruses for Cancer Therapy

Vicent Tur-Planells, Adolfo Garcia-Sastre, Sara Cuadrado-Castano, Estanislao Nistal-Villan

Summary: This review provides an overview of non-human-adapted RNA viruses used in cancer therapy and the diverse strategies employed to optimize their therapeutic capabilities. Through this article, we gain insights into the promising advancements in virotherapy and its potential to revolutionize cancer treatment.

VACCINES (2023)

No Data Available